Page 1 of Clinical Trials for "Denileukin diftitox", 46 Total Matches
- 1CompletedLast Updated: February 7, 2012Condition(s): Leukemia; Systemic Mastocytosis
- 2TerminatedLast Updated: October 27, 2009Condition(s): Anaplastic Large-Cell Lymphoma
- 3Active, not recruitingLast Updated: August 17, 2011Condition(s): Multiple Myeloma
- 4AvailableLast Updated: April 4, 2012Condition(s): Cancer
- 5CompletedLast Updated: May 25, 2011Condition(s): Kidney Cancer
- 6Active, not recruitingLast Updated: November 15, 2011Condition(s): Fallopian Tube Cancer; Ovarian Clear Cell Cystadenocarcinoma; Ovarian Endometrioid Adenocarcinoma; Ovarian Mixed Epithelial Carcinoma; Ovarian Mucinous Cystadenocarcinoma; Ovarian Serous Cystadenocarcinoma; Ovarian Undifferentiated Adenocarcinoma; Peritoneal Cavity Cancer; Recurrent Ovarian Epithelial Cancer; Stage III Ovarian Epithelial Cancer; Stage IV Ovarian Epithelial Cancer
- 7CompletedLast Updated: May 14, 2012Condition(s): Graft-Versus-Host Disease
- 8RecruitingLast Updated: May 18, 2012Condition(s): Stage IIIC Melanoma; Stage IV Melanoma
- 9Active, not recruitingLast Updated: March 17, 2012Condition(s): Leukemia, Adult T-Cell
- 10RecruitingLast Updated: September 13, 2011Condition(s): Metastatic Pancreatic Cancer
- 11Active, not recruitingLast Updated: November 2, 2011Condition(s): HER2-positive Breast Cancer; Recurrent Breast Cancer; Recurrent Non-small Cell Lung Cancer; Recurrent Ovarian Epithelial Cancer; Recurrent Ovarian Germ Cell Tumor; Stage IV Breast Cancer; Stage IV Non-small Cell Lung Cancer; Stage IV Ovarian Epithelial Cancer; Stage IV Ovarian Germ Cell Tumor
- 12Recruiting
- 13Active, not recruitingLast Updated: June 7, 2011Condition(s): Male Breast Cancer; Recurrent Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer; Stage IV Breast Cancer
- 14CompletedLast Updated: April 13, 2012Condition(s): Non-Hodgkin's Lymphoma
- 15CompletedLast Updated: April 27, 2012Condition(s): Malignant Melanoma
- 16TerminatedLast Updated: December 2, 2011Condition(s): Recurrent Melanoma; Stage III Melanoma; Stage IV Melanoma
- 17Active, not recruitingLast Updated: August 27, 2009Condition(s): Lymphoma, T-Cell, Peripheral
- 18RecruitingLast Updated: June 5, 2009Condition(s): Peripheral T-Cell Lymphoma
- 19CompletedLast Updated: February 29, 2008Condition(s): Lymphoma, T-Cell, Cutaneous
- 20RecruitingLast Updated: June 14, 2011Condition(s): Melanoma
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?intr=%22Denileukin+diftitox%22
